Compare compound mechanisms, evidence quality, related research topics, receptor considerations, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | GHK-Cu | Triple Agon… |
|---|---|---|
| GLP-1R (Glucagon-like peptide-1 receptor) | ||
| GIPR (Glucose-dependent insulinotropic polypeptide receptor) | ||
| GcgR (Glucagon receptor) | ||
| Y2R (Y2 receptor) | ||
| Copper-dependent enzyme systems / connective-tissue gene expression axis |
A structured review of the evidence for this stack
Sign in to build a structured evidence review for GHK-Cu + Triple Agonist — mechanisms, evidence, endpoints, and limitations grounded in documented research.
Aggregate research activity for this selection
3 researchers have logged this combination on VialTalk
Related research topics in matching journals
Forum discussions on this stack
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.
